Importance of biliary excretion of indomethacin in gastrointestinal and hepatic injury

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 8 PART2, 2008, Pages

  Dial, Elizabeth J ^a,b   Darling, Rebecca L ^a   Lichtenberger, Lenard M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Bile; Gastrointestinal tract; Indomethacin; Liver; Phosphatidylcholine

Indexed keywords

BILE SALT; DEOXYCHOLATE SODIUM; INDOMETACIN; PHOSPHATIDYLCHOLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIARY EXCRETION; DIGESTIVE SYSTEM INJURY; DRUG CYTOTOXICITY; DRUG EXCRETION; DRUG MECHANISM; ERYTHROCYTE; HEMOLYSIS; LIVER CELL; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 48549094983     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05266.x     Document Type: Article

References (24)

1. Coleman R, Iqbal S, Godfrey PP, Billington D. Composition of several mammalian biles and their membrane-damaging properties. Biochem. J. 1979 178 : 201 8.
2. El-Hariri LM, Marriott C, Martin GP. The mitigating effects of phosphatidylcholines on bile salt- and lysophosphatidylcholine-induced membrane damage. J. Pharm. Pharmacol. 1991 44 : 651 64.
3. Velardi ALM, Groen AK, Oude RPJ, Van der Meer R, Palascinano G, Tytgat GNJ. Cell type-dependent effect of phospholipid and cholesterol on bile salt cytotoxicity. Gastroenterology 1991 101 : 457 64.
4. Puglielli L, Amigo L, Arrese M et al. Protective role of biliary cholesterol and phospholipid lamellae against bile acid-induced cell damage. Gastroenterology 1994 107 : 244 54.
5. Narain PK, DeMaria EJ, Heuman DM. Lecithin protects against plasma membrane disruption by bile salts. J. Surg. Res. 1998 78 : 131 6.
6. Inagaki T, Moschetta A, Lee Y-K et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. PNAS 2006 103 : 3920 5.
7. Barrios JM, Lichtenberger LM. Role of biliary phosphatidylcholine in bile acid protection and NSAID injury of the ileal mucosa in rats. Gastroenterology 2000 118 : 1179 86.
8. Venneman NG, Pettruzzelli M, Van Dijk JE et al. Indomethacin disrupts the protective effect of phosphatidylcholine against bile salt-induced ileal mucosa injury. Eur. J. Clin. Invest. 2006 36 : 105 12.
9. Komichi D, Tazuma S, Nishioka T, Hyogo H, Une M, Chayama K. Unique inhibition of bile salt-induced apoptosis by lecithins and cytoprotective bile salts in immortalized mouse cholangiocytes. Dig. Dis. Sci. 2003 48 : 2315 22.
10. Tsuboi K, Tazuma S, Nishiofa T, Chayama K. Partial characterization of cytoprotective mechanisms of lecithin against bile salt-induced bile duct damage. J. Gastroenterol. 2004 39 : 955 60.
11. Lacroix I, Lapeyre-Mestre M, Bagheri H, Pathak A, Montastruc JL. Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care. Fundam. Clin. Pharmacol. 2004 18 : 201 6.
12. Lapeyre-Mestre M, deCastro AM, Bareille MP et al. Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems. Fundam. Clin. Pharmacol. 2006 20 : 391 5.
13. Duggan DE, Hooke KF, Noll RM, Kwan KC. Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem. Pharmacol. 1975 25 : 1749 54.
14. Beck WS, Schneider HT, Dietzel K, Nuernberg B, Brune K. Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Physicochemical and biochemical factors involved. Arch. Toxicol. 1990 64 : 210 17.
15. Lichtenberger LM, Wang Z-M, Romero JJ et al. Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat. Med. 1995 1 : 154 8.
16. Giraud M-N, Motta C, Romero JJ, Bommelaer G, Lichtenberger LM. Interaction of indomethacin and naproxen with gastric surface-active phospholipids. A possible mechanism for the gastric toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs). Biochem. Pharmacol. 1999 57 : 247 54.
17. Shih DM, Kast-Woelbern HR, Wong J, Xia YR, Edwards PF, Lusis AJ. A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids. J. Lipid Res. 2006 47 : 384 92.
18. Rust C, Bauchmuller K, Bernt C et al. Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers. Gut 2006 55 : 718 27.
19. Brune K, Dietzel K, Nurnberg B, Schneider HT. Recent insight into the mechanism of gastrointestinal tract ulceration. Eur. J. Rheumatol. Inflamm. 1987 9 : 8 14.
20. Petruzzelli M, Moschetta A, Renooij W et al. Indomethacin enhances bile salt detergent activity: relevance for NSAIDs-induced gastrointestinal mucosal injury. Dig. Dis. Sci. 2006 51 : 766 74.
21. Petruzzelli M, Vacca M, Moschetta A et al. Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts. Clin. Biochem. 2007 40 : 503 10.
22. Jacob M, Foster R, Sigthorsson G, Simpson R, Bjarnason I. Role of bile in pathogenesis of indomethacin-induced enteropathy. Arch. Toxicol. 2007 81 : 291 8.
23. Treinen-Moslen M, Kanz MF. Intestinal tract injury by drugs: importance of metabolite delivery by yellow bile road. Pharmacol. Ther. 2006 112 : 649 67.
24. Leung YB, Urbanski Y, Myers RP. Rofecoxib-induced hepatotoxicity: a forgotten complication of the coxibs. Can. J. Gastroenterol. 2006 20 : 351 5.